Exploring the impact of supervised consumption service use on public injecting in Toronto, Canada


Author: Greenwald ZR, Bouck Z, Eeuwes J, Clark R, Atkinson K, Hopkins S, Tookey P, Greig S, Bonn M, Scheim AI, Werb D

Theme: Epidemiology & Public Health Research Year: 2024

Background: Among people who inject drugs, injecting in public or semi-public spaces has been linked to increased risks of HIV, hepatitis C, and overdose. Supervised consumption services (SCS) provide sterile safe spaces to inject – however evidence on their effects on public injecting, particularly during the synthetic opioid-driven North American overdose epidemic, remains limited. We therefore sought to investigate the potential association between SCS and public injecting in Toronto, Canada.

Methods: Cross-sectional analysis of the Ontario integrated Supervised Injection Services (OiSIS-Toronto) cohort, including people who inject drugs in Toronto, Canada (2018-2020). We describe the prevalence of recent (past 6 month) frequent public injecting (completing >75% of injections in public/semi-public spaces, e.g. parks, bathrooms, alleyways) and recent sociostructural, drug-related, and harm reduction characteristics.
We estimate the effect of SCS use on frequent public injecting using Poisson regression.

Results: Among 701 people who inject drugs (65% cis-male, 56% daily injecting, 85% with any recent SCS use), 15% (N=108) reported frequent public injecting. Relative to those with infrequent/no public injecting, those who inject in public were younger (median age [Interquartile Range]: 36 [31-45] vs 40 [33-50]), and more likely to be Indigenous (42% vs 32%), and report recent housing instability (77% vs 40%), syringe sharing (35% vs 20%), incarceration (44% vs 34%), and non-fatal overdose (47% vs 37%) (all p<0.05). Recent SCS use (any vs no use), was associated with a 43% lower prevalence of frequent public injection (adjusted prevalence ratio: 0.57, 95% confidence interval: 0.35–0.94).

Conclusions: We found SCS use was associated with decreases in public injecting, indicating its benefit for reducing public drug use and drug-related harms. Future research should focus on addressing the needs of people who do not access SCS or for whom SCS access does not meaningfully impact public injecting behaviours. 

Download abstract